Ibutamoren for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Ibutamoren for Health & Longevity

Created on 07/28/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

Ibutamoren is an oral compound that raises the body's own growth hormone. Its most consistent effects are more of this growth signal and lean body mass, with weaker support for sleep and bone. Offsetting these are higher blood sugar, fluid retention, and strong hunger. Whether raising this signal helps or harms long-term health remains unresolved; it is unapproved and unregulated. (Full Review)

Protocol

Dose
10–25 mg
Once daily, oral; 10–12.5 mg limits appetite and metabolic effects, 25 mg is the trial dose
Timing
Bedtime
Aligns with night-time growth hormone pulse; morning if hunger disrupts sleep
Frequency
Single daily dose
Growth-signal elevation sustained over 24 h; splitting offers no advantage
Time to effect
IGF-1 rise
Within days
Near-maximal within weeks
Body composition
2–3 months
Continues over 6–12 months
Sleep & appetite
First week
Often noticed early in treatment

Benefits

Contraindications
  • Active or prior cancer
  • Diabetes or significant prediabetes
  • Congestive heart failure (NYHA Class III–IV)
  • Uncontrolled hypertension
  • Moderate-to-severe untreated sleep apnea
  • Pregnancy or breastfeeding
  • Children and adolescents
  • Competitive athletes subject to anti-doping testing
    •
Key Interactions
  • Glucose-lowering drugs (insulin, metformin, sulfonylureas, SGLT2 inhibitors)
  • Corticosteroids and calcium-channel blockers
  • NSAIDs (ibuprofen, naproxen)
  • Other GH/IGF-1-raising supplements and peptides
  • Exogenous growth hormone
    •

Risk & Side Effects

  • High: Reduced insulin sensitivity and elevated blood sugar; fluid retention and peripheral edema; increased appetite and unwanted weight/fat gain
    •
  • Medium: Joint pain, muscle pain, and stiffness; elevated cortisol and prolactin; elevated IGF-1 and theoretical cancer promotion
    •
  • Low: Worsening of heart failure or blood pressure via fluid retention
    •
  • Speculative: Pro-aging effects of chronically elevated GH/IGF-1; harms from unregulated, contaminated, or mis-dosed product
    •

Monitoring

Marker Target Why
IGF-1 Mid-normal for age and sex; below upper reference limit Confirms the compound is working and flags excessive, potentially harmful elevation
Fasting glucose 75–90 mg/dL Detects the blood-sugar-raising effect early
HbA1c < 5.4% Captures sustained blood-sugar rise a single reading may miss
Fasting insulin 2–6 µIU/mL Reveals worsening insulin resistance before glucose rises
Morning cortisol ~9–15 µg/dL (drawn ~8 a.m.) Screens for the transient cortisol rise ibutamoren can cause
Prolactin Men < 15 ng/mL; women < 20 ng/mL Screens for the prolactin rise that can affect libido and breast tissue
Lipid panel (LDL, HDL, triglycerides) LDL < 100 mg/dL; triglycerides < 90 mg/dL Tracks metabolic effects
Free T4 Mid-normal reference GH stimulation can shift thyroid-hormone handling

Cadence: Baseline before starting; recheck at 6–12 weeks, then every 3–6 months, with prompt rechecking after any dose increase

Qualitative Assessment

  • Sleep quality: depth, night-time awakenings, and morning restedness
  • Energy and recovery: daytime energy, training recovery, and soreness
  • Appetite control: whether hunger is manageable or driving unwanted eating
  • Swelling and joints: ankle/limb puffiness, rapid weight changes, and joint or muscle aches
  • Body composition: waist measurement and periodic DXA scan
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.